Found: 33
Select item for more details and to access through your institution.
A phase 2 study of a brachyury‐targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 22, p. 3845, doi. 10.1002/cncr.35477
- By:
- Publication type:
- Article
Predictors of survival after resection of primary sarcomas of the chest wall—A large, single‐institution series.
- Published in:
- Journal of Surgical Oncology, 2018, v. 118, n. 3, p. 518, doi. 10.1002/jso.25162
- By:
- Publication type:
- Article
The immune landscape of undifferentiated pleomorphic sarcoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1008484
- By:
- Publication type:
- Article
Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.997506
- By:
- Publication type:
- Article
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1763, doi. 10.3390/cancers16091763
- By:
- Publication type:
- Article
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1707, doi. 10.3390/cancers16091707
- By:
- Publication type:
- Article
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 904, doi. 10.3390/cancers16050904
- By:
- Publication type:
- Article
Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4701, doi. 10.3390/cancers14194701
- By:
- Publication type:
- Article
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5249, doi. 10.3390/cancers13205249
- By:
- Publication type:
- Article
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1283, doi. 10.3390/cancers11091283
- By:
- Publication type:
- Article
MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 677, doi. 10.3390/cancers11050677
- By:
- Publication type:
- Article
A tool for discovering drug sensitivity and gene expression associations in cancer cells.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176763
- By:
- Publication type:
- Article
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338
- By:
- Publication type:
- Article
Outcome of First‐Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 110, doi. 10.1634/theoncologist.2017-0574
- By:
- Publication type:
- Article
Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 71, doi. 10.1634/theoncologist.2016-0025
- By:
- Publication type:
- Article
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1271, doi. 10.1634/theoncologist.2016-0464
- By:
- Publication type:
- Article
Immuno-genomic landscape of osteosarcoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14646-w
- By:
- Publication type:
- Article
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cause of Death in Patients With Lower-Risk Myelodysplastic Syndrome.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2174, doi. 10.1002/cncr.24984
- By:
- Publication type:
- Article
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30874-8
- By:
- Publication type:
- Article
Clear Cell Chondrosarcoma: Clinical Characteristics and Outcomes in 15 Patients.
- Published in:
- Sarcoma, 2020, p. 1, doi. 10.1155/2020/2386191
- By:
- Publication type:
- Article
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
- Published in:
- Neurosurgical Focus, 2024, v. 56, n. 5, p. 1, doi. 10.3171/2024.2.FOCUS2416
- By:
- Publication type:
- Article
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
- By:
- Publication type:
- Article
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
- Published in:
- Rare Tumors, 2024, p. 1, doi. 10.1177/20363613241271669
- By:
- Publication type:
- Article
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 2, p. 377, doi. 10.1007/s11060-023-04432-1
- By:
- Publication type:
- Article
Outcomes of systemic therapy in metastatic phyllodes tumor of the breast.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 3, p. 871, doi. 10.1007/s10549-021-06116-8
- By:
- Publication type:
- Article
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4282, doi. 10.1002/cam4.5298
- By:
- Publication type:
- Article
Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells
- Published in:
- Molecular Oncology, 2011, v. 5, n. 1, p. 93, doi. 10.1016/j.molonc.2010.10.003
- By:
- Publication type:
- Article
Epidemiology and therapies for metastatic sarcoma.
- Published in:
- Clinical Epidemiology, 2013, v. 5, p. 147, doi. 10.2147/CLEP.S28390
- By:
- Publication type:
- Article
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.
- Published in:
- Sarcoma, 2020, p. 1, doi. 10.1155/2020/8363986
- By:
- Publication type:
- Article
Treatment of Recurrent or Metastatic Uterine Adenosarcoma.
- Published in:
- Sarcoma, 2017, p. 1, doi. 10.1155/2017/4680273
- By:
- Publication type:
- Article
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0668-z
- By:
- Publication type:
- Article